Ryan Murtagh, MD
Diagnostic Neuroimaging · El Segundo, CANPI 1548396997
Payments from drug & device makers
Across 197 payments — averaging $3855.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$206K
- Boehringer Ingelheim Espana S.A.$198K
- Merck$165K
- Takeda Pharmaceuticals U.S.A., Inc.$80K
- Boehringer Ingelheim RCV GmbH & Co KG$62K
- Stryker$28K
- plus $22K from 11 others
Across 20 payments — averaging $5512.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$78K
- Regeneron$25K
- Y-mabs Therapeutics, Inc.$7K
What the payments were for
- Consulting fees$253,97799%
- Food & beverage$1,6821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 17 | $205,632 |
| Boehringer Ingelheim Espana S.A. | 10 | $198,190 |
| Merck | 100 | $164,589 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $80,275 |
| Boehringer Ingelheim RCV GmbH & Co KG | 4 | $61,585 |
| Stryker | 10 | $27,803 |
| Biomarin Pharmaceutical Inc. | 2 | $11,150 |
| Genentech, Inc. | 6 | $8,685 |
| Penumbra, Inc. | 7 | $882 |
| Bracco Diagnostics Inc. | 7 | $359 |
| Thrombolex, Inc. | 1 | $138 |
| AstraZeneca | 1 | $125 |
| Philips North America LLC | 1 | $61 |
| Boston Scientific | 1 | $53 |
| Immedica Pharma US, Inc. | 1 | $23 |
| Bayer | 1 | $21 |
| Neuropace, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENVIMA$111,983
- PRADAXA$58,620
- MK-4280$35,220
- CASCADIA INTERBODY SYSTEM$18,813
- KEYTRUDA$8,537
- CASCADIA$8,080
- RAVINE$8,080
- EVEREST$8,080
- CAPRI CORPECTOMY CAGE SYSTEM$910
- Indigo$448
- Indigo System$278
- Bashir Endovascular Catheter$138
- ULTOMIRIS$125
- MULTIHANCE$104
How this compares
$759,590 in reported general payments places this provider in the 95th percentile of 26 diagnostic neuroimaging providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic neuroimaging in El Segundo
- Jeremy HeitStanford$290K
- Gregory ZaharchukStanford$135K
- Daniel ChowOrange$75K
- Nancy PhamStanford$71K
- Seena DehkharghaniStanford$65K
- Laila MaladWestlake Village$6K
- Michael ZeinehStanford$5K
- Michael IvStanford$4K
- Andrew ChiuStanford$576
- Dale JamisonStanford$254
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.